KTTA - Pasithea Therapeutics Corp
0.8
0.004 0.438%
Share volume: 127,009
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$0.80
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-13-2024 | 03-24-2025 | 05-15-2025 | 11-13-2025 | |
| Assets | |||||||
| Total Assets | 22.408 M | 17.663 M | 18.637 M | 16.065 M | 14.659 M | 13.631 M | |
| Current Assets | 13.193 M | 8.642 M | 9.779 M | 7.368 M | 6.125 M | 5.529 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 104.649 K | 104.654 K | 98.333 K | 142.945 K | 162.454 K | 19.665 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 12.009 M | 7.968 M | 9.361 M | 6.923 M | 5.341 M | 4.123 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 136.491 K | 131.776 K | 127.060 K | 122.343 K | 117.522 K | 0.000 | |
| Other Assets | 9.079 M | 8.889 M | 8.732 M | 8.574 M | 8.417 M | 8.101 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 22.408 M | 17.663 M | 18.637 M | 16.065 M | 14.659 M | 13.631 M | |
| Total liabilities | 2.525 M | 1.488 M | 823.975 K | 1.282 M | 1.680 M | 1.424 M | |
| Total current liabilities | 2.467 M | 1.395 M | 660.397 K | 1.120 M | 1.595 M | 1.377 M | |
| Accounts Payable | 2.434 M | 1.395 M | 660.397 K | 1.120 M | 1.326 M | 1.338 M | |
| Other liabilities | 57.650 K | 93.272 K | 163.578 K | 162.172 K | 85.305 K | 46.871 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 57.650 K | 93.272 K | 163.578 K | 162.172 K | 85.305 K | 46.871 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 19.883 M | 16.175 M | 17.813 M | 14.783 M | 12.979 M | 12.207 M | |
| Common stock | 59.068 M | 59.229 M | 64.254 M | 64.373 M | 66.125 M | 72.088 M | |
| Retained earnings | -39.179 M | -43.046 M | -46.405 M | -49.583 M | -53.146 M | -59.900 M |